Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease

NCT04026165 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

384

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Kidney Disease

Interventions

DRUG: SEL
DRUG: Placebo

Sponsor

Gilead Sciences